Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

International Bioprinting Congress

Published: Monday, August 04, 2014
Last Updated: Monday, August 04, 2014
Bookmark and Share
Select Biosciences South East Asia is pleased to report on the success of the inaugural International Bioprinting Congress, which took place at the Biopolis, Singapore on the 24-25 July 2014.

The event featured Keynote Presentations from Professor Chua Chee Kai, Director NTU Additive Manufacturing Centre, Singapore and Professor Makoto Nakamura, Graduate School of Science and Engineering for Research, University of Toyama, Japan.

The world’s leading experts presented their latest research covering all aspects of 3D Bioprinting to an international audience and then opened up the floor to lively panel discussions on each afternoon.

Topics discussed at the event included;

• Additive Manufacturing in Tissue Engineering : Current state-of-the-art on 3D Scaffolds
• 4D Bioprinting : biofabrication of rod-like and tubular tissue engineered constructs using programmable self-folding bioprinted biomaterials
• Peptide Inks : Bio-printing Self-Assembling Ultrashort Peptides to Build Nanofibrous Scaffolds for Regenerative Medicine Applications
• Microfluidic Cell Patterning Technique for Multicellular Dynamics Studies
• Regulatory Updates on Cellular and Tissue-based Products
• The Patent Landscape of Bioprinting
• The concepts of the challenges for the developments of Bioprinting and Biofabrication
• Organ Printing as an Information Technology : Towards Tissue and Organ Informatics
• 3D Bioprinting – Bioassembly Robots and Bioinks
• Magnetic 3D Bioprinting for High-Throughput Drug Screening
• Bioprinting interfaces for 2D and 3D Cell and Tissue models
• Multi-photon processing - a versatile technology platform for the development of standard bio-mimetic microenvironments for 3D cell culture
• A New Approach for 3D Tissue & Organ Fabrication Inspired From Orthopaedic Surgery
• 3D Bioprinting of Human Embryonic Stem Cells

The highly topical panel discussions covered the following areas;

Day 1 - Intellectual Property Landscape / Ethics Surrounding Bioprinting Human Parts and Tissue / Regulatory Path Forward

Day 2 - Easiest Tissue and Organ to Bioprint / Technology Advancement and Innovation for Bioprinting / How far are we realistically from the Clinic?

The audience also took advantage of a complimentary tour of the NTU Additive Manufacturing Centre, hosted by Professor Chua. Here the attendees were able to learn about the latest research at the facility which was enabled by the major investment Nanyang Technological University has undertaken.

The feedback for the event was exemplary with some of the attendees quoted as saying: 

“From a Co-Chair perspective, I am very pleased, the meeting was well organised and covered all aspects of the subject, from the scientific techniques through to intellectual property, moving forward in to the next advancements we can expect to see in the field. I am already looking forward to next year’s meeting.” Professor Chua Chee Kai, Director NTU Additive Manufacturing Centre, Singapore.

“Very good, gathered together many excellent speakers, I will definitely be involved next year.” Professor Makoto Nakamura, Graduate School of Science and Engineering for Research, University of Toyama, Japan.

Outstanding science, engineering, intellectual property and regulatory discussions” Dr. Stuart Williams, Director, University of Louisville, USA.

“The most exciting conference I have ever attended. Very inspiring and very well organised.” Dr. Vladimir Mironov, Visiting Professor, Centre for Information Technology Renato Archer, Brazil.

“Very stimulating, I really enjoyed it. It was a pleasure to be here with the leaders in the field. Great debates about the future developments to come.” Dr. Weinmao (Will) Shu, Associate Professor, Heriot Watt University, UK.

“Very good, well done, great organisation, I would like to be involved next year.” Dr. Aleksandr Ovsianikov, Asst. Professor, Vienna University of Technology, Austria.

“Hot, important growing area and Select Biosciences is helping to lead the way. The panel discussions were especially innovative.” Dr. Mark DeCoster, Associate Professor, Biomedical Engineering, Louisiana Tech University, USA.

Next year’s event will also take place in Singapore, the dates are the 9-10 July, 2015. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

The Clinical Applications of Stem Cells, 26-27 February, 2015, Singapore.
The Singapore Bioimaging Consortium and Select Biosciences South East Asia are pleased to report on the success of The Clinical Applications of Stem Cells, which took place at The Academia, Singapore General Hospital Campus, Singapore on the 26-27 February 2015.
Monday, March 16, 2015
Select Biosciences India Honors Prof Bhupinder Singh Bhoop with “Outstanding Scientist Award”
Presentation made at the QbD in Pharma Development conference in Mumbai, India on February 24-25, 2015.
Tuesday, March 11, 2014
Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Designer Cell Fate Switches Could Streamline Stem Cell Biology
Researchers develop new method of reprogramming cells between cell types in a more efficient way than before.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
More Effective Strategy for Producing Flu Vaccines
Researchers have developed a virus backbone, allowing producers to grow vaccine viruses in mammalian cells, rather than in eggs.
Soil Carbon Release Might Equal U.S. Emissions
Research suggests 55M tons of carbon will be release from soils by 2050, 17% higher than prjected emissions.
Inspiring Futuristic Innovation: Brain ‘Organoids’
Scientists create artificial brains, providing an advanced model for studying brain tumour development.
Predicting Leukaemia Development in Cancer Patients
Biomarker may predict which formerly treated cancer patients will develop highly fatal form of leukemia.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!